Major COVID drug bites the dust.
Merck’s Covid-19 pill was no better than placebo in lowering the risk of hospitalization
Oct. 7, 2022 4:14pm
Major COVID drug bites the dust—Merck’s #COVID-fighting antiviral #molnupiravir failed to prevent #COVID19 hospitalizations/deaths is a large trial of ~25,000 people, despite drug shortening recovery time & lowering viral load. Damn—COVID19 is a tough nut.
https://www.statnews.com/pharmalot/2022/10/07/covid19-merck-molnupiravir-fda-mhr…